Tiyodora Akbulut
About Tiyodora Akbulut
Tiyodora Akbulut is a QC Associate Scientist specializing in CAR T Bioanalytical at Bristol Myers Squibb in the United States.
Company
Tiyodora Akbulut is currently employed at Bristol Myers Squibb, a globally recognized pharmaceutical company known for its innovative work in the field of biopharmaceutical research. Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Tiyodora Akbulut holds the position of QC Associate Scientist, CAR T Bioanalytical at Bristol Myers Squibb. In this role, Tiyodora is responsible for conducting quality control activities related to CAR T cell therapy, ensuring that bioanalytical processes meet the rigorous standards required for this advanced medical treatment.
Background
Tiyodora Akbulut has a background in quality control within the CAR T therapy field. Prior to the current role, Tiyodora worked as a CAR T Quality Control Analyst at Bristol Myers Squibb from 2020 to 2021. This experience has contributed to a strong understanding of the quality control processes essential for CAR T bioanalytical work.
Experience in CAR T Quality Control
With experience as a CAR T Quality Control Analyst at Bristol Myers Squibb, Tiyodora Akbulut has a solid foundation in quality control specific to CAR T cell therapy. This earlier role involved ensuring the integrity and safety of CAR T cell products, which are crucial for developing effective treatments in immunotherapy.
Current Role at Bristol Myers Squibb
Since June 2021, Tiyodora Akbulut has been working as a QC Associate Scientist, CAR T Bioanalytical at Bristol Myers Squibb. In this capacity, Tiyodora continues to build on past experience, contributing expertise to the quality control of CAR T cell therapies. This role requires careful attention to bioanalytical methodologies and a commitment to maintaining high standards in the production of CAR T treatments.